BTK-IN-22
BTK-IN-22 is a BTK inhibitor (IC50: 0.9 nM). BTK-IN-22 also inhibits BLX and BMX with IC50s of 1.4 and 1.2 nM respectively. BTK-IN-22 shows improved kinase selectivity compared to Ibrutinib (HY-10997)
For research use only. We do not sell to patients.
- CAS No.: 2573048-10-7
- Formula: C26H26N6O2
- Molecular Weight:454.52
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
In Vitro
BTK-IN-23 (Compound 2) inhibits BTK autophosphorylation in Jeko-1 cells, with an IC50 of 109 nM[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:Jeko-1 cell
-
Concentration:0.01, 0.1, 1, 10 μM
-
Incubation Time:2 h
-
Result:Inhibited BTK autophosphorylation.
Chemical Information
-
CAS No. 2573048-10-7
-
Molecular Weight 454.52
-
Formula C26H26N6O2
-
SMILES
CC(C=C(C=C1)OC2=CC=CC=C2)=C1C3=NN(C4=NC=NC(N)=C43)[C@@H]5CCCN(C5)C(C=C)=O
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)